If lawmakers want lower drug prices, they should strengthen competitive pressure, not regulate it into passivity. The politics are easy to understand. Attacking middlemen polls well. It allows lawmakers to appear tough on prices without directly confronting manufacturers. But the economics are less forgiving. Lower drug prices require bargaining power. Congress has just reduced it. Patients and taxpayers will bear the cost.
Warning : [minor] The ExtractEmbedded option may find more tags in the media data，更多细节参见体育直播
На шее Трампа заметили странное пятно во время выступления в Белом доме23:05，这一点在一键获取谷歌浏览器下载中也有详细论述
Цены на один вид жилья в России снизились20:41。关于这个话题，体育直播提供了深入分析
Марина Совина (ночной редактор)